So we now know the Brazil trials are on going, they may take two months longer, but we aren't Pfizer. For the FDA they are a continuation of CD12, so if they "failed to meet their endpoints" why are they not cancelled? Duh, duh and duh!!! What do we gain if they are successful?

First it will really help us with Long Haulers and because Remdesivir won't feel threatened, we could become the go to therapeutic. And other indications will be easier to get approvals.

We still have 1300 people dying a day in here, that's 400,000 a year. Even if it goes down a bunch, covid19 is still going to need a therapeutic. Covid 19 is not going away, right now China is in lock down. A spike could happen with the war in the Ukraine and refugees. There will be a new variant.

We were on the verge of way too many breakthroughs to view this as the whole company blew up and nothing is happening. No, it takes time for an approval for a small biotech, lots of time, but we will soon have news of success and the NP fiasco will be explained.